Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bristol-Myers Squibb Company acquires iPierian Inc


Tuesday, 29 Apr 2014 07:00am EDT 

Bristol-Myers Squibb Company:Acquires all of iPierian Inc issued and outstanding shares of capital stock and all common stock equivalents in all cash transaction for purchase price of $175 mln.Says with potential for additional development and regulatory milestone payments totaling $550 mln, along with future royalties on net sales.Transaction is expected to be accounted for as asset acquisition for Bristol-Myers Squibb resulting in $175 mln charge during second quarter of 2014. 

Company Quote

51.12
0.11 +0.22%
30 Jul 2014